BRUSSELS - Today, the Anticancer Fund (ACF) announces that Saar Sinnaeve has joined the organisation as communication manager.

Saar will be responsible for conceiving and executing communication strategies that engage a variety of target audiences and effectively deliver the key messages of the organisation. In addition, she will help to develop and disseminate public relations’ tactics to increase the visibility among stakeholders and help secure more funding for independent, patient centered clinical trial opportunities across Europe and even beyond.

Lydie Meheus, CEO: “Saar is a highly experienced and capable communications professional. She will continue to improve upon our effort in finding support for investigating new, non-commercial treatment options and reaching out to patients to help solve their problems.”

Guy Buyens, Medical Director: “Until recently, we received help from a consultant to convey our messages to the outside world. But now we reached a threshold where an in-house specialist like Saar becomes indispensable.”

Commenting on her new role, Saar says: "It’s a real pleasure to be part of such a dynamic and engaged organisation. My major aim is to maximize this fantastic resource of people, partners and projects to achieve a better understanding and awareness of how The Anticancer Fund contributes to fight against cancer”.

Extensive experience

Until now Saar was a journalist at De Tijd, the leading business newspaper in Belgium. She covered the health industry and medical innovations, with publications in the newspaper and in the different digital channels.

Before starting at De Tijd she was editor-in-chief of ‘De Groene Leidraad’/‘Le Fil Vert’, a newspaper for internal communication at Bank Brussel Lambert (BBL), now ING.

Saar has a Master in Communication, with a specialisation in Public Relations, from Institut des Hautes Etudes des Communications Sociales (IHECS). Subsequently she got a postgraduate degree in Marketing at the Hogeschool-Universiteit Brussel, the Brussels campus of KU Leuven.